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A case-control study of ocular surface squamous neoplasia
(OSSN) in Uganda
Keith Waddell1, James Kwehangana1, William T. Johnston2, Sebastian Lucas3, Robert Newton2
1 Ruharo Eye Hospital, Uganda
2 Epidemiology and Genetics Unit, University of York, United Kingdom
3GKT School of Medicine, St. Thomas’ Hospital, London, United Kingdom
HIV increases the risk of OSSN. Here we investigate other factors in a case-control study from Uganda with 318 cases (48 CIN
I, 66 CIN II, 81 CIN III and 123 with invasive disease) and 762 controls. Initial analyses were stratified by HIV serostatus (204
cases and 202 controls were HIV seropositive), but since findings were similar in infected and uninfected people, the
combined results are presented here. The risk of OSSN increased with increasing time spent in direct sunlight (ptrend 5 0.003,
adjusted for age, sex, residential district and HIV serostatus): compared to those who reported spending up to 1 hr a day in
direct sunlight, the risk was 1.7 (95% Confidence Interval [CI] 1.2–2.4) in those reporting 2–4-hr exposure and 1.8 (95% CI
1.1–3.1) in those reporting 51 hr. The risk was also increased among people reporting a previous injury to the affected eye
(OR 2.4, 95% CI 1.2–4.5). Pinguecula in the nasal quadrant of the unaffected eye were evident on clinical examination for
98% of cases (293/300) and for 91% of the same quadrant in the right eye (246/271) of controls (OR 5 6.4, 95% CI 2.5–
16.1). We confirm associations with exposure to solar ultraviolet radiation and with the presence of pinguecula and report a
role for previous ocular trauma in the aetiology of OSSN. We did not identify any additional factors that point to an
underlying infectious cause, although this is an area of on-going research.
In the years before the HIV epidemic, corneo-conjunctival
intraepithelial neoplasia (CIN) and carcinoma (together
called ocular surface squamous neoplasia (OSSN)) were
reported to be more frequent in African countries, such as
Uganda, than in Europe and the USA.1 Since the 1980s there
has been a marked increase in cases of conjunctival neoplasia,
mostly in sub-Saharan Africa and a link with HIV infection
has been conﬁrmed (reviewed in Ref. 2). The clear excess
risk of ocular surface epithelial dysplasias among HIV
infected people (and among immunosuppressed renal trans-
plant recipients) suggests a possible role for an underlying
infection in the aetiology.2,3 Various HPV types (including
cutaneous types) have been identiﬁed in some, but not in all,
tumor specimens from several small case series but results
from case-control studies have, to date, been inconclusive.2
Here, we describe a case-control study of OSSN conducted in
Uganda, with a view to identifying risk factors, other than
infection with HIV. In particular, we examined socioeco-
nomic and demographic factors that might be relevant to the
transmission of, or exposure to, infectious disease and speciﬁc
factors that might cause irritation to the eye. A primary aim
was to accrue biological material to aid in the hunt for an
underlying infectious cause. However, although an active
search for oncogenic infections is ongoing, no new candidate
virus (if one exists) has yet been identiﬁed.4
Material and Methods
Between November 2001 and February 2005, in country-wide
ophthalmology clinics across Uganda, anyone with a sus-
pected ocular surface squamous neoplasia was offered surgi-
cal treatment and histology, together with enrolment into a
case-control study. Serological testing for HIV was also
offered, after pre-test counseling from appropriately qualiﬁed
research staff, in the local language. Information about the
disease, its treatment and HIV testing and the research pro-
ject was provided in private in vernacular by counselors and
consent was conﬁrmed by signature or thumbprint. Follow-
ing fully informed consent, each patient completed a brief
questionnaire asking about various social and demographic
variables, exposure to solar ultraviolet radiation and factors
that may be related to the transmission of, or exposure to, in-
fectious disease. In addition, factors that might cause irrita-
tion to the eye were examined, such as exposure to smoke
from cooking ﬁres. A sample of venous blood was obtained
for onsite HIV testing, with conﬁrmation at the Uganda Vi-
rus Research Institute (2 enzyme immunoassay tests in paral-
lel, with Western blot if required)—the remaining material
was stored for future use. Ocular lesions were photographed
and details of eye and general health were recorded,
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including various ophthalmological clinical parameters for
the majority. Data were computerized and checked by 1 of
the investigators (KW), using EPI INFO (Version 6). Lesions
judged removable leaving a normal eye, were dealt with as
described in Ref. 5. If this was impossible, enucleation was
advised. If too advanced for this, incision biopsy was per-
formed to conﬁrm diagnosis and referral offered for further
management. Surgery was carried out by 1 of the investiga-
tors (KW). Larger lesions were stored in a RNA ﬁxative and
then put into liquid nitrogen for future use. A sample of all
lesions was stored in formalin and sent to St Thomas’ Hospi-
tal, London, in the United Kingdom for histological review
by 1 of the investigators (SL), in 1 of many frequent ship-
ments. Final histology was fed back to local investigators in a
timely fashion to inform clinical decisions. CIN was classiﬁed
into 3 stages according to one, two or three thirds thickness
being dysplastic; invasive tumors were diagnosed when the
basement membrane was breached. In addition, the nasal
quadrant of the unaffected eye was examined for clinical evi-
dence of allergy, hyperaemia, pigmentation, pinguecula and
pterygia.
Over the same time period, controls were recruited from
2 sources. The ﬁrst group comprised patients attending the
ophthalmology clinics with concerns or conditions other than
OSSN. This group also included those individuals who were
originally recruited as cases, but where histology subsequently
revealed another diagnosis. Of the 295 individuals recruited
from this source, 170 turned out to have a normal eye, 39
had Kaposi’s sarcoma, 18 had retinitis, 18 had uveitis, 17 had
infection with herpes simplex virus, 15 had cataract and the
remainder had a variety of other conditions. Many of these
people were recruited at the Ruharo Eye Hospital in Mbarara.
These individual had details of their ocular examination
recorded, including an examination of the nasal quadrant of
the right eye, where possible, for clinical evidence of allergy,
hyperaemia, pigmentation, pinguecula and pterygia. The sec-
ond group of controls comprised people who were recruited
through the voluntary HIV counseling and testing service—
this source was used in an effort to recruit more people who
may have had a diagnosis of HIV and these individuals did
not undergo an ocular examination (and so are excluded
from analyses that used data obtained on clinical examina-
tion). Following informed consent (as described above), ques-
tionnaire data, ophthalmological examinations, and HIV tests
were obtained (when possible) and recorded as for cases. Eth-
ical approval for this study was obtained from the Science
and Ethics Committee of the Uganda Virus Research Insti-
tute and from the Uganda National Council for Science and
Technology.
Initial exploration of the relationship between OSSN and
sex, age and residential district was done using Mantel-
Haenszel v2 (FREQ procedure, the SAS System). Preliminary
analyses were all stratiﬁed by HIV serostatus serostatus (204
cases and 202 controls were HIV seropositive), but revealed
little difference in results between HIV seropositive and sero-
negative people and so all other factors were assessed using
logistic regression models (GENMOD procedure, the SAS
System), adjusting for age, sex, residential district and HIV
serostatus. These results are presented in this article, with the
exception of Table 5, which shows key ﬁndings stratiﬁed by
HIV serostatus. Analyses of clinical variables included all
cases and only those controls recruited from the ophthalmol-
ogy clinic who had an ocular examination (Table 4). For
each variable, a category of ‘‘missing values’’ was created and
included in regression models, but the odds ratios for this
group are not reported (and excluded altogether when testing
for trend). An additional set of analyses was constructed that
included self-reported daily hours in the sun as an adjust-
ment, but it made little difference to the results (data not
shown). Finally, analyses were conducted, restricting the con-
trol group to those individuals with other eye conditions and
restricting the case group to those with invasive disease only,
or excluding CIN I, but again, the results change little (data
not shown).
Results
Of the 395 people approached as possible cases, 318 with
conﬁrmed OSSN (48 CIN I, 66 CIN II, 81 CIN III and 123
with invasive disease), an HIV test result and a complete, or
partially complete questionnaire, agreed to participate and
are included in the analyses presented here. Similarly, 762 of
794 possible controls are included. Table T11 shows the distri-
bution of cases and of controls by sex, age, HIV serostatus
and residential district. In accord with previous studies, there
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Table 1. Distribution of cases with ocular surface squamous
neoplasia and of controls, with respect to sex, age, HIV serostatus
and residential district
Cases (n 5 318) Controls (n 5 762)
Percentage/number Percentage/number
Sex
Male 43% (137) 42% (320)
Female 57% (181) 58% (442)
Age (years)
15–29 24% (76) 36% (273)
30–44 59% (187) 51% (391)
45þ 17% (55) 13% (98)
HIV serostatus
Positive 64% (204) 27% (202)
Negative 36% (114) 73% (560)
Residential district
Kampala 14% (43) 3% (26)
Masaka 15% (48) 4% (34)
Mbarara 14% (45) 49% (376)
Elsewhere 52% (166) 42% (321)
Missing 5% (16) 1% (5)
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were more women than men diagnosed with OSSN and
nearly two thirds of cases were between the ages of 30 and
44 years old; as expected, the majority were HIV seropositive.
Although the proportion of controls with evidence of infec-
tion with HIV was lower, the actual number of HIV seropos-
itive controls was similar to cases (204 cases and 202 con-
trols). Nearly half of controls were recruited from 1 centre
(Ruharo Eye Hospital in Mbarara)—this compared to only
14% of cases.
Table T22 shows the association between various socio-demo-
graphic and lifestyle factors in relation to the risk of OSSN.
Factors relating to education and income were not related to
risk, and neither were exposure to tobacco or household smoke
from cooking ﬁres. The self-reported number of lifetime sexual
partners was not related to risk, arguing against an underlying
sexually transmitted cause. Although relevant for only a small
number of cases (25), a self reported history of ocular trauma
in the affected eye was associated with an excess risk of ocular
surface squamous neoplasia (OR ¼ 2.4, 95% CI 1.2–4.3).
When results were stratiﬁed by HIV serostatus (Table 5), the
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Table 3. Distribution of cases with ocular surface squamous
neoplasia and of controls, with respect to factors that might relate
to exposure to solar ultraviolet radiation
Number of
cases/
controls
Odds ratio (95%
confidence
intervals
Place of work
Indoors 81/176 1.0
Indoor and outdoor 82/326 0.8 (0.5–1.3)
Outdoor 118/198 1.7 (1.1–2.6)
Hours spent in direct sunlight/day
1 hr 136/402 1.0
2–4 hrs 129/289 1.7 (1.2–2.4)
5þ hrs 33/63 1.8 (1.1–3.1)
v
2(trend) ¼ 8.7,
p ¼ 0.003
Hours spent cultivating/week
None 81/137 1.0
1–9 174/478 1.0 (0.7–1.5)
10þ 43/138 1.2 (0.7–2.1)
v
2(trend) ¼ 0.1,
p ¼ 0.7
Typically wear sun hat
No 255/684 1.0
Yes 42/63 1.3 (0.8–2.2)
Typically wear sunglasses
No 278/722 1.0
Yes 19/28 1.2 (0.6–2.3)
Note: numbers do not always add to the total because of missing
values. Odds ratios adjusted for age, sex, HIV serostatus and district of
residence.
Table 2. Distribution of cases with ocular surface squamous
neoplasia and of controls, with respect to various socio-
demographic and lifestyle factors
Number of
cases/
controls
Odds ratio (95%
confidence
intervals
Education
None or some
primary school
102/228 1.0
At least complete
primary school
178/351 0.8 (0.6–1.2)
Paid work
No 77/132 1.0
Yes 212/588 0.8 (0.6–1.2)
Of those who have paid work
Full-time 77/146 1.0
Part-time 129/441 0.9 (0.6–1.3)
Monthly income (Ug. shilling)
20thþ 125/290 1.0
Up to 20th 95/327 1.1 (0.8–1.6)
Accommodation
Owned by participant 196/546 1.0
Rented 66/93 1.1 (0.7–1.7)
Other 28/113 0.6 (0.4–1.0)
Main household cook
No 125/273 1.0
Yes 173/482 1.0 (0.6–1.6)
If yes, cook indoors/outdoors
Outdoors 24/111 1.0
Indoors 124/320 1.3 (0.7–2.4)
Tobacco use
Nonsmoker 257/642 1.0
Ex-smoker 19/75 0.8 (0.4–1.4)
Current smoker 23/37 1.3 (0.7–2.5)
Number self-reported lifetime sexual partners
0–3 162/409 1.0
4þ 130/302 0.9 (0.7–1.3)
Number of hand washes/day
0–4 120/383 1.0
5þ 164/341 1.1 (0.8–1.5)
Previously seen eye doctor for any condition
No 280/714 1.0
Yes 17/38 0.7 (0.3–1.3)
Previous injury to affected eye (cases), or any eye in controls
No 270/720 1.0
Yes 25/27 2.4 (1.2–4.3)
Note: numbers do not always add to the total because of missing
values. Odds ratios adjusted for age, sex, HIV serostatus and district of
residence.
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ﬁndings appeared similar in both groups although among HIV
seronegative people they were not statistically signiﬁcant.
TableT3 3 shows the association between OSSN and factors that
might relate to exposure to solar ultraviolet radiation. Com-
pared to those with indoor occupations, outdoor workers were
at an increased risk (OR ¼ 1.7, 95% CI 1.1–2.6) and the risk
increased signiﬁcantly with increasing self-reported hours spent
in direct sunlight each day (ptrend ¼ 0.003); when these ﬁnd-
ings were stratiﬁed by HIV serostatus (Table 5), the results for
HIV seropositive people were not statistically signiﬁcant.
The relationship between OSSN and factors identiﬁed on
clinical examination of the unaffected eye are shown in Table
T44. The presence of allergic reactions, hyperaemia, pigmentation
and pterygium show no association with disease. In contrast,
pinguecula in the unaffected eye were visible on clinical exami-
nation of the right nasal quadrant for 98% of cases (293/300)
and for 91% of the same quadrant in the right eye (246/271)
of controls (OR ¼ 6.4, 95% CI 2.5–16.1). The ﬁndings were
evident in HIV infected and uninfected people (Table T55).
Discussion
A primary aim of this study was to identify underlying infec-
tious factors in the aetiology of OSSN. Therefore, the collec-
tion of biological material from cases and from controls, in
which presence of infection can be measured, was considered
of paramount importance. However, results in relation to
HPV remain unclear (and are published elsewhere)2 and
since no other infection (if there is one) has been identiﬁed,
we have as yet, made no further use of any of this material.
Since associations between oncogenic infections and the can-
cers they cause tend to be strong, coupled with the inherent
practical difﬁculties of recruiting people in resource-poor set-
tings, our choice of control group was made on pragmatic
grounds. The inclusion of people with ‘‘other eye diseases,’’
together with the need to boost the proportion of HIV
infected people in the comparison group (nearly half of
whom came from only 1 centre), may have biased our ﬁnd-
ings and we acknowledge that this is the principle weakness
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Table 4. Factors identified on clinical examination of the nasal
quadrant of the unaffected eye of cases with ocular surface
squamous neoplasia and of the nasal quadrant of the right eye in
controls
Number of
cases/controls
Odds ratio (95%
confidence intervals
Allergy
No 300/266 1.0
Yes 0/6 –
Hyperaemia
No 261/234 1.0
Yes 39/38 0.7 (0.4–1.2)
Pigmentation
No 60/57 1.0
Yes 240/215 1.2 (0.8–2.0)
Pinguecula
No 7/25 1.0
Yes 293/246 6.4 (2.5–16.1)
Pterygium
No 293/263 1.0
Yes 7/9 0.5 (0.2–1.4)
Note: these analyses were restricted to the 295 controls recruited from
the ophthalmology clinic; for the majority, the results of ocular
examination were recorded. Odds ratios adjusted for age, sex, HIV
serostatus and district of residence.
Table 5. Selected risk factors for ocular surface squamous neoplasia, stratified by HIV serostatus
HIV seronegative HIV seropositive
Number of
cases/controls
Odds ratio
(95% confidence
intervals
Number of
cases/controls
Odds ratio (95%
confidence intervals
Previous injury to affected eye (cases), or any eye in controls
No 96/523 1.0 174/197 1.0
Yes 10/23 2.0 (0.9–4.6) 15/4 3.4 (1.0–11.3)
Hours spent in direct sunlight/day
1 hr 42/286 1.0 94/116 1.0
2–4 hrs 44/213 1.7 (1.1–2.8) 85/76 1.6 (1.0–2.7)
5þ hrs 20/53 2.2 (1.1–4.2) 13/10 1.3 (0.5–3.5)
v
2(trend) ¼ 5.9, p ¼ 0.02 v2(trend) ¼ 2.8, p ¼ 0.1
Pinguecula
No 3/14 1.0 4/11 1.0
Yes 106/174 4.4 (1.0–16.8) 189/72 7.3 (2.2–24.4)
Note: numbers do not always add to the total because of missing values. Odds ratios adjusted for age, sex and district of residence. Analyses of
clinical variables were restricted to the 294 controls who were recruited from the ophthalmology clinic and who therefore had an ocular
examination.
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of the work presented here. However, extensive sensitivity
analyses outlined above demonstrate the robustness of key
ﬁndings, which are also supported by other published studies
and are evident in HIV infected and uninfected people. Of
particular note, is the lack of any evidence (other than an
association with HIV) suggesting underlying infection as a
possible cause.
Results presented here in relation to self-reported time
spent in direct sunlight and occupation lend further support
to the importance of exposure to solar ultraviolet radiation as
a cause of OSSN. Lesions occur in sun-exposed areas of the
eye,5,6 are associated with solar elastosis and have been
shown to contain classical UV-induced p53 mutations.5–9
The incidence of the tumor increases with increasing levels
of ambient solar radiation and associations with sun exposure
and past history of skin cancer have also been identiﬁed in
other case-control studies.1,10–12 These ﬁndings are perhaps
unsurprising given the similarity of this disease with cutane-
ous squamous cell carcinoma, for which UV exposure is an
established cause.13
Exposure to dust and ocular trauma have been sug-
gested as possible risk factors for OSSN, although, until
now, evidence was scant and based only on case
reports.14,15 We found an increased risk in association
with a self-report of prior trauma to the affected eye; this
is the ﬁrst time the risk has been identiﬁed in an observa-
tional epidemiological study. It is important to note, how-
ever, that it was an exposure that was relevant for only 8%
of cases and that further information on the precise na-
ture of the previous eye injury was not available. In addi-
tion, the possibility of bias, due to better recall of trauma
in subjects with OSSN than in controls, should also be
considered.
In 1979, Clear et al. examined 234 conjunctival biopsies in
Africans from Malawi. They speculated that solar keratosis,
pinguecula and pterygium are present as a continuous spec-
trum of the same pathological process, eventually leading to
carcinomatous change in a small proportion of affected indi-
viduals.7 Pinguecula and to a lesser extent pterygium have
been linked to exposure to solar UV in subsequent studies,
although the evidence relating to the nature of that associa-
tion remains relatively sparse.16,17 Although common among
cases and controls, the association between the presence of
pinguecula and risk of OSSN is evident, with 98% of cases
(all but 7 people) having clinically identiﬁed pinguecula in
the contra-lateral eye, as compared to 91% of controls. Con-
versely, pterygium was relatively rare in both cases and con-
trols and no associations with OSSN were identiﬁed. Of note
however, is that diagnoses of pinguecula and pterygium were
made on clinical grounds alone; there was no histological
veriﬁcation.
In summary, in this—the largest case-control study of
OSSN ever conducted—we conﬁrm associations with expo-
sure to solar ultraviolet radiation and with the presence of
pinguecula and report a role for previous ocular trauma in
the aetiology of the disease. We did not identify any socioe-
conomic or demographic factors that might point to an
underlying infectious cause (other than infection with HIV),
although the identiﬁcation of such an infection is an area of
on-going research.
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